Showing results (2721-2730 of 4,619) with videos related to

Sort By:
Pageof 462
Chemmedchem|November 20, 2012
Combining quantum mechanical ligand conformation analysis and protein modeling to elucidate GPCR-ligand binding modesSabine Schultes, Harald Engelhardt, Luc Roumen, et al.
Chemmedchem|November 22, 2012
Discovery of Schaeffer's acid analogues as lead structures of mycobacterium tuberculosis type II dehydroquinase using a rational drug design approachMarco F Schmidt, Oliver Korb, Nigel I Howard, et al.
Chemmedchem|August 10, 2013
Inhibition of human α-methylacyl CoA racemase (AMACR): a target for prostate cancerAndrew J Carnell, Ralph Kirk, Matthew Smith, et al.
Chemmedchem|October 13, 2011
From a library of MAG antagonists to nanomolar CD22 ligandsStefanie Mesch, Katrin Lemme, Matthias Wittwer, et al.
Chemmedchem|October 13, 2011
Why as a medicinal chemist I am not optimistic about the possibility of finding, in a reasonable timeframe, small-molecule drugs capable of curing the evolution of Alzheimer's diseaseJean-Louis Kraus
Chemmedchem|August 10, 2011
Synthesis and antiproliferative activity of some ellipticine-like 11H-pyrido[a]carbazole derivativesMaria Grazia Ferlin, Ornella Gia, Lisa Dalla Via
Chemmedchem|July 28, 2011
(S)- and (R)-fluoxetine as native markers in mass spectrometry (MS) binding assays addressing the serotonin transporterMarielle Hess, Georg Höfner, Klaus T Wanner
Chemmedchem|November 5, 2011
Platinum(II) phenanthroimidazoles for targeting telomeric G-quadruplexesKatherine J Castor, Johanna Mancini, Johans Fakhoury, et al.
Chemmedchem|August 2, 2011
Synthesis and antitumor molecular mechanism of agents based on amino 2-(3',4',5'-trimethoxybenzoyl)benzo[b]furan: inhibition of tubulin and induction of apoptosisRomeo Romagnoli, Pier Giovanni Baraldi, Carlota Lopez-Cara, et al.
Chemmedchem|September 14, 2011
Identification of inhibitors of the Leishmania cdc2-related protein kinase CRK3Laura A T Cleghorn, Andrew Woodland, Iain T Collie, et al.
Pageof 462